Sign in
Taking people in United StatesPhase 4

Famotidine and Antacids for Treatment of Dyspepsia

Key facts

Who runs it
Stony Brook University
Where
Stony Brook, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 4
People taking part
80 people, planned
Started
9 Nov 2023
Expected to end
31 Dec 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Intravenous Famotidine
  • Oral Maalox/ Mylanta
Record updated
2 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Subject Age ≥ 18 years of age
  • Patient diagnosed with dyspepsia
  • Present at the ED with upper abdominal pain score of at least 3

Who cannot take part

  • Inability to tolerate oral medications
  • Proton pump inhibitor within 2 hours of study treatment
  • Hypersensitivity to an ingredient in Maalox/ Mylanta or Famotidine
  • Moderate to Severe Renal Insufficiency (precaution)
  • Kidney Failure
  • Pregnant or Nursing
  • Verbal pain score less than 3
  • Bowel Obstruction

Where in United States

  • Stony Brook University HospitalStony Brook, United StatesContact: Andrea GowieTaking people

About the trial

What the trial wants to find out

The aim of this study is to compare intravenous famotidine, an H2 receptor antagonist, and Maalox/ Mylanta, an oral antacid, in treatment of dyspepsia in the emergency department. The goal of this study is to reduce patients' pain based on the verbal numerical pain scale. The anticipated outcome is for pain levels in both groups to decrease. It is expected that antacids will improve symptoms more quickly and to a greater degree within an hour of taking medication based on the results of similar studies.

The 2 groups in the trial

  • Intravenous FamotidineExisting treatment, for comparison

    Patients in this group will receive 20 mg of intravenous famotidine.

  • Oral MaaloxExisting treatment, for comparison

    Patients in the group will receive 30 ml of oral Maalox/ Mylanta.

    Treatment: Oral Maalox/ Mylanta

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparing Intravenous Famotidine and Oral Antacids in the Treatment of Dyspepsia in the Emergency Department
Record updated
2 June 2026